The U.S. FDA has issued an Emergency Use Authorization to permit the emergency use of Eli Lilly’s Investigational Monoclonal Antibody Therapy Bamlanivimab for the treatment of mild to moderate virus.
The U.S. FDA has issued an Emergency Use Authorization to permit the emergency use of Eli Lilly’s Investigational Monoclonal Antibody Therapy Bamlanivimab for the treatment of mild to moderate virus.
